ELEVATED NEPHROGENOUS CYCLIC AMP WITH NORMAL SERUM PARATHYROID HORMONE LEVELS IN PATIENTS WITH LUNG CANCER
- 1 July 1980
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 51 (1), 167-169
- https://doi.org/10.1210/jcem-51-1-167
Abstract
Total and nephrogenous urinary cyclic AMP (cAMP), serum Parathyroid Hormone (PTH) and ionized calcium (Ca) levels were determined in 8 normal subjects, and 16 normocalcemic and 9 hypercalcemic patients with lung cancer. Total and nephrogeneous cAMP levels were significantly increased in both normocalcemic and hypercalcemic lung cancer patients, as compared to normal subjects. There was no significant correlation between serum PTH and total or nephrogenous cAMP in the cancer group. The factors responsible for the elevated nephrogenous cAMP in the lung cancer patients are not known.Keywords
This publication has 4 references indexed in Scilit:
- Radioimmunoassay of parathyroid hormone (parathyrin) in monkey and man.Clinical Chemistry, 1977
- Nephrogenous Cyclic Adenosine Monophosphate as a Parathyroid Function TestJCI Insight, 1977
- Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.JCI Insight, 1977
- Renal cyclic adenosine monophosphate: An accurate index of parathyroid functionMetabolism, 1976